methylene blue has been researched along with Cardiovascular Pregnancy Complications in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkayam, U; Gherman, RB; Goodwin, TM; Hameed, A | 1 |
| Crews, JK; Granger, JP; Herrington, JN; Khalil, RA | 1 |
2 other study(ies) available for methylene blue and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy.
Topics: Administration, Inhalation; Adult; Eisenmenger Complex; Epoprostenol; Fatal Outcome; Female; Humans; Hypoxia; Injections, Intravenous; Labor Stage, Second; Methemoglobinemia; Methylene Blue; Nitric Oxide; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Vasodilator Agents | 1999 |
Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat.
Topics: Acetylcholine; Animals; Aorta; Blood Pressure; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Hypertension; Methylene Blue; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Phenylephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Sprague-Dawley; Uterus; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2000 |